Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 21, 2016
- Accepted June 1, 2016
- Published online July 8, 2016.
Article Versions
- Earlier version (June 2, 2016 - 08:42).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Xue-Qing Li,
- Martin A. Hayes,
- Gunnar Grönberg,
- Kristina Berggren,
- Neal Castagnoli Jr., and
- Lars Weidolf
- Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
- Address correspondence to:
Dr. Xue-Qing Li, Cardiovascular and Metabolic Diseases, Drug Metabolism and Pharmacokinetics, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal 431 83, Sweden. E-mail: xueqing.li{at}astrazeneca.com